The National Institutes of Health and the Best Pharmaceuticals for Children Act

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.11, Iss.1, 2009-01, pp. : 45-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does peer review at the US National Institutes of Health need modifying?

Reproductive BioMedicine Online, Vol. 16, Iss. 2, 2008-02 ,pp. : 238-238

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Does peer review at the US National Institutes of Health need modifying?

Reproductive BioMedicine Online, Vol. 16, Iss. 3, 2008-03 ,pp. : 390-390

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Best research for best health: a new national health research strategy

By Evans Timothy W

Clinical Medicine, Vol. 6, Iss. 5, 2006-10 ,pp. : 435-437

Royal College Of Physicians

Access to resources Recommend Favorite

Nature's Medicines: Traditional Knowledge and Intellectual Property Management. Case Studies from the National Institutes of Health (NIH), USA

Current Drug Discovery Technologies, Vol. 2, Iss. 4, 2005-12 ,pp. : 203-219

Bentham Science Publishers

Access to resources Recommend Favorite

Prediagnostic lifestyle factors and survival after colon and rectal cancer diagnosis in the National Institutes of Health (NIH)-AARP Diet and Health Study

By Pelser Colleen Arem Hannah Pfeiffer Ruth M. Elena Joanne W. Alfano Catherine M. Hollenbeck Albert R. Park Yikyung

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1540-1547

Blackwell Publishing

Access to resources Recommend Favorite